Connect with us

News

RFK Jr. says annual COVID-19 shots no longer advised for healthy children and pregnant women – a public health expert explains the new guidance

Published

on

file 20250528 56 tbtzj3.jpg?ixlib=rb 4.1
Until now, the CDC has recommended that everyone ages 6 months and older get a yearly COVID-19 vaccine. Asiaselects via Getty Images
Libby Richards, Purdue University On May 27, 2025, Health and Human Services Secretary Robert F. Kennedy Jr. announced that the Centers for Disease Control and Prevention will no longer include the COVID-19 vaccine on the list of immunizations it recommends for healthy children and pregnant women. The announcement, made in a video posted on the social platform X, comes on the heels of another announcement, made on May 20, in which the Food and Drug Administration revealed that it will approve new versions of the vaccine only for adults 65 years of age and older and for people with one or more risk factors for severe COVID-19 outcomes. The agency will require vaccine manufacturers to conduct clinical trials to demonstrate that the vaccine benefits low-risk groups. The Conversation U.S. asked Libby Richards, a nursing professor from Purdue University involved in public health promotion, to explain what these announcements mean for the general public.

Why are HHS and FDA diverging from past practice?

Currently, getting a yearly COVID-19 vaccine is recommended for everyone ages 6 months and older, regardless of their health risk. In the video announcing the plan to remove the vaccine from the CDC’s recommended immunization schedule for healthy children and healthy pregnant women, Kennedy spoke alongside National Institutes of Health Director Jay Bhattacharya and FDA Commissioner Marty Makary. The trio cited a lack of evidence to support vaccinating healthy children. They did not explain the reason for the change to the vaccine schedule for pregnant people, who have previously been considered at high-risk for severe COVID-19. Similarly, in the FDA announcement made a week prior, Makary and the agency’s head of vaccines, Vinay Prasad, said that public health trends now support limiting vaccines to people at high risk of serious illness instead of a universal COVID-19 vaccination strategy.

Was this a controversial decision or a clear consensus?

Many public health experts and professional health care associations have raised concerns about Kennedy’s latest announcement, saying it contradicts studies showing that COVID-19 vaccination benefits pregnant people and children. The American College of Obstetrics and Gynecology, considered the premier professional organization for that medical specialty, reinforced the importance of COVID-19 vaccination during pregnancy, especially to protect infants after birth. Likewise, the American Academy of Pediatrics pointed to the data on hospitalizations of children with COVID-19 during the 2024-to-2025 respiratory virus season as evidence for the importance of vaccination. Kennedy’s announcement on children and pregnant women comes roughly a month ahead of a planned meeting of the Advisory Committee on Immunization Practices, a panel of vaccine experts that offers guidance to the CDC on vaccine policy. The meeting was set to review guidance for the 2025-to-2026 COVID-19 vaccines. It’s not typical for the CDC to alter its recommendations without input from the committee.
Robert F. Kennedy Jr. has removed COVID-19 vaccines from the vaccine schedule for healthy children and pregnant people.
FDA officials Makary and Prasad also strayed from past established vaccine regulatory processes in announcing the FDA’s new stance on recommendations for healthy people under age 65. Usually, the FDA broadly approves a vaccine based on whether it is safe and effective, and decisions on who should be eligible to receive it are left to the CDC, which bases its decision on the advisory committee’s research-based guidance. The advisory committee was expected to recommend a risk-based approach for the COVID-19 vaccine, but it was also expected to recommend allowing low-risk people to get annual COVID-19 vaccines if they want to. The CDC’s and FDA’s new policies on the vaccine will likely make it difficult for healthy people to get the vaccine.

What conditions count as risk factors?

The CDC lists several medical conditions and other factors that increase peoples’ risk for severe COVID-19. These conditions include cancer, diabetes, heart disease, obesity, chronic kidney disease and some lung conditions like COPD and asthma. Pregnancy is also on the list. The article authored by Makary and Prasad describing the FDA’s new stance on the vaccine also contain a lengthy list of risk factors and notes that about 100 million to 200 million people will fall into this category and will thus be eligible to get the vaccine. Pregnancy is included. Reversing the recommendation for vaccinating healthy pregnant women thus contradicts the new framework described by the FDA. Studies have documented that COVID-19 vaccines are safe during pregnancy and may reduce the risk of stillbirth. A study published in May 2025 using data from 26,783 pregnancies found a link between COVID-19 infection before and during pregnancy and an increased risk for spontaneous abortions. Importantly, a 2024 analysis of 120 studies including a total of 168,444 pregnant women with COVID-19 infections did not find enough evidence to suggest the infections are a direct cause of early pregnancy loss. Nonetheless, the authors did state that COVID-19 vaccination remains a crucial preventive measure for pregnant women to reduce the overall risk of serious complications in pregnancy due to infection. Immune changes during pregnancy increase the risk of severe illness from respiratory viruses. Vaccination during pregnancy also provides protection to the fetus that lasts into the first few months of life and is associated with a lower risk of COVID-19 related hospitalization among infants.
Rite-Aid sign advertising COVID-19 vaccines
Change is coming to COVID-19 vaccine policy. Rick Obst, CC BY-SA
The changes to the CDC’s and the FDA’s plan for COVID-19 vaccines also leave out an important group – caregivers and household members of people at high risk of severe illness from infection. This omission leaves high-risk people more vulnerable to exposure to COVID-19 from healthy people they regularly interact with. Multiple countries with risk-based vaccination policies do include this group.

What about vaccines for children?

High-risk children age 6 months and older who have conditions that increase the risk of severe COVID-19 are still eligible for the vaccine. Existing vaccines already on the market will remain available, but it is unclear how long they will stay authorized and how the change in vaccine policy will affect childhood vaccination overall. To date, millions of children have safely received the COVID-19 vaccine. Data on whether children benefit from annual COVD-19 vaccines is less clear. Parents and clinicians make vaccination decisions by weighing potential risks with potential benefits.

Will low-risk people be able to get a COVID-19 shot?

Not automatically. Kennedy’s announcement does not broadly address healthy adults, but under the new FDA framework, healthy adults who wish to receive the fall COVID-19 vaccine will likely face obstacles. Health care providers can administer vaccines “off-label”, but insurance coverage is widely based on FDA recommendations. The new, narrower FDA approval will likely reduce both access to COVID-19 vaccines for the general public and insurance coverage for COVID-19 vaccines. Under the Affordable Care Act, Medicare, Medicaid and private insurance providers are required to fully cover the cost of any vaccine endorsed by the CDC. Kennedy’s announcement will likely limit insurance coverage for COVID-19 vaccination. Overall, the move to focus on individual risks and benefits may overlook broader public health benefits. Communities with higher vaccination rates have fewer opportunities to spread the virus. This is an updated version of an article originally published on May 22, 2025. Libby Richards, Professor of Nursing, Purdue University This article is republished from The Conversation under a Creative Commons license. Read the original article.

Discover more from Daily News

Subscribe to get the latest posts sent to your email.

Continue Reading
Advertisement Sports Research

Daily News

Metro Board to Consider Locally Preferred Alternative for Sepulveda Transit Corridor Project

Metro Board will consider Modified Alternative 5 as the Locally Preferred Alternative for the Sepulveda Transit Corridor Project on January 22, 2026, a major step toward improving transit between the San Fernando Valley and LA’s Westside.

Published

on

Illustrated infographic showing the proposed Sepulveda Transit Corridor route connecting Van Nuys Metrolink Station to the E Line Expo/Sepulveda Station with a G Line connection along Van Nuys Boulevard.
Image credit: LA Metro

On Thursday, January 22, 2026, at 10:00 AM, the Metro Board will consider selecting a Locally Preferred Alternative (LPA) for the Sepulveda Transit Corridor Project. This milestone could significantly improve mobility options between the San Fernando Valley and the of Los Angeles.

Proposed Alternative

After a technical evaluation and reviewing more than 8,000 public comments from the Draft Environmental Impact Report (Draft EIR) period, Metro staff has proposed Modified Alternative 5 as the LPA. This underground heavy rail line would run between the Van Nuys Metrolink Station and the E Line Expo/Sepulveda Station with a key connection to the G Line at Van Nuys Boulevard.

Modified Alternative 5 combines the benefits of Alternative 5—high ridership, frequent service, and shorter station construction sites—while avoiding geographic challenges in the Santa Monica Mountains. It also incorporates connectivity advantages from Alternative 6 along Van Nuys Boulevard, reducing the overall project length and anticipated costs, and increasing direct connections to Metro’s growing transit network.

Next Steps

If approved, Metro would advance project development for the LPA, including:

  • Evaluating phasing and the Public/Private Partnership (P3) delivery model
  • Identifying value engineering opportunities
  • Refining designs to allow G Line connection at Van Nuys Boulevard
  • Continuing environmental review and community outreach

Public Participation

Residents, businesses, and institutions are encouraged to provide feedback:

  • Attend in person: Sign up on the tablets in the Metro Headquarters lobby before 9:45 AM.
  • Email comments: BoardClerk@metro.net (comments received before 5 PM on January 21, 2026, will be sent to the full Board)
  • Watch live: boardagendas.metro.net

Why This Matters

The Sepulveda Transit Corridor Project will connect the San Fernando Valley to the Westside, addressing the natural barrier of the Santa Monica Mountains and relieving congestion on the I-405. It will provide a fast, safe, and reliable alternative to the freeway and strengthen LA’s regional transit network.

Disclaimer: Station locations and construction timelines are subject to change. Project availability may vary. Public input is encouraged before final decisions are made.

Continuing Coverage: STM Daily News will continue to follow developments surrounding the Sepulveda Transit Corridor Project, including Metro Board decisions, environmental review updates, community input opportunities, and the project’s long-term impact on transportation across Los Angeles.

For the latest updates, in-depth reporting, and transportation-focused coverage, visit STM Daily News.

Author


Discover more from Daily News

Subscribe to get the latest posts sent to your email.

Continue Reading

News

Major Popeyes Franchisee Sailormen Files for Chapter 11 — What It Means for Restaurants and the Economy

Sailormen Inc., a major Popeyes franchisee operating 130+ locations in Florida and Georgia, filed for Chapter 11 on Jan. 15, 2026 amid rising costs and heavy debt. Many restaurants are expected to remain open as restructuring continues.

Published

on

Exterior Popeyes Louisiana Kitchen restaurant sign and storefront representing Sailormen Inc.’s Chapter 11 bankruptcy filing affecting 130+ locations in Florida and Georgia.
Sailormen Bankruptcy: What Chapter 11 Means for Popeyes Restaurants in FL and GA

A major Popeyes Louisiana Kitchen franchise operator is heading to bankruptcy court — but the headline does notmean Popeyes corporate is filing, or that every restaurant involved is about to close.

Sailormen Inc., a Miami-based Popeyes franchisee that has operated in the system since 1987, filed for Chapter 11 bankruptcy protection on Jan. 15, 2026. The company operates more than 130 Popeyes locations across Florida and Georgia (some industry coverage puts the count at 136), making it one of the chain’s largest franchise groups in the region.

Franchisee filing, not a Popeyes corporate bankruptcy

This case involves Sailormen (the operator) — not Popeyes corporate and not parent company Restaurant Brands International.

In a message referenced in industry reporting, Popeyes leadership said Sailormen’s filing does not reflect the overall health of the Popeyes brand, and that a large majority of Sailormen’s restaurants are expected to remain open while the company restructures.

What pushed Sailormen into Chapter 11

Court-related summaries and industry coverage point to a familiar mix of pressures hitting restaurant operators:

  • Inflation and higher operating costs (food, labor, and day-to-day expenses)
  • Higher borrowing costs as interest rates climbed
  • Liquidity strain, including reports of falling behind on rent and facing pressure from landlords and vendors
  • Legal disputes, including vendor-related claims tied to unpaid balances

The failed store sale that worsened the situation

One key detail: Sailormen reportedly tried to sell 16 Georgia restaurants to stabilize finances. That deal fell through, and the company remained responsible for lease guarantees tied to those locations — a liability that can linger even if other stores are performing.

The debt and the lender pressure

Industry reporting describes Sailormen as carrying a heavy debt load — cited at about $130 million overall.

More detailed figures cited in coverage include:

  • Over $112 million in unpaid principal loan balance
  • Over $17 million in accrued interest and fees

Reporting also points to pressure from BMO (BMO Bank), described as Sailormen’s largest lender. In December 2025, BMO reportedly sought to appoint a receiver, a move that can displace management and take control of a company’s assets. Sailormen’s Chapter 11 filing allows the company to continue operating as a debtor-in-possession while it attempts to reorganize.

Why this matters for “Food” and “Our Economy”

This isn’t just a Popeyes story — it’s a snapshot of what happens when restaurant operators face higher costsvalue-conscious consumers, and more expensive debt at the same time.

Chapter 11 is designed to reorganize a business, not automatically liquidate it. For customers, the near-term impact may be limited if most locations stay open.

STM Daily News will follow this story as it develops, including any updates on store operations, restructuring plans, and potential sales of locations.


Sources


For more food business headlines and how they connect to the real economy, follow STM Daily News.

Advertisement
Get More From A Face Cleanser And Spa-like Massage

Authors


Discover more from Daily News

Subscribe to get the latest posts sent to your email.

Continue Reading

Food and Beverage

Diva Fam Inc. Announces Voluntary Recall of True Sea Moss “Sea Moss Gel Superfood” Products Due to Possible Health Risk

Diva Fam Inc. is recalling all True Sea Moss Sea Moss Gel Superfood flavors nationwide due to missing pH/temperature records and potential botulism risk.

Published

on

smoothie in bottles berries and green leaves. True Sea Moss recall
Photo by Polina Tankilevitch on Pexels.com

Diva Fam Inc.. announced a voluntary recall of all lots and flavors of its True Sea Moss brand Sea Moss Gel Superfood due to a lack of required regulatory authorization and temperature monitoring records for pH-controlled food products, according to a company statement released January 9, 2026.

The company said the recall applies to products manufactured prior to January 9, 2026. The manufacture date (MFD) is indicated on the can lid in MM/YYYY format.

Why the products are being recalled

Diva Fam said the recall is related to missing required regulatory authorization and temperature monitoring records for certain pH-controlled food products. The company noted that pH-controlled foods that are not manufactured in accordance with applicable regulatory requirements may present a potential risk of microbial growth, including organisms that can produce toxins associated with botulism.

Diva Fam TrueSeaMossContainer
TrueSeaMoss Container

Botulism is a rare but serious illness that can affect the nervous system. Symptoms may include general weakness, dizziness, double vision, difficulty speaking or swallowing, and, in severe cases, difficulty breathing or muscle weakness.

Diva Fam said no illnesses or adverse health events have been reported in connection with the products subject to this recall to date.

Where the products were sold

The affected products were distributed nationwide through select retail locations, online via https://truеsеamоss.cоm/, and other distribution channels, according to the company.

Recalled products (all flavors, all lots)

The recall includes all flavors and sizes and batch numbers of True Sea Moss brand Sea Moss Gel Superfood packaged in 16 FL OZ (473 mL) glass jars, manufactured prior to January 9, 2026.

Diva Fam TrueSeaMossPackaging
True Sea Moss Packaging

Recalled flavors and UPCs

FlavorUPC
Mango5065006235875
Pineapple5065006235288
Wildcrafted5065006235073
Apple and Cinnamon5065006235776
Elderberry5065006235189
Passion Fruit5061033691882
Blue Spirulina and Raspberry5065006235813
Strawberry5065006235271
Cherry5061033691264
Mango and Pineapple5065006235301
5 Blends in 15061033690052
Soursop5061033691875
Lemon Pie5061033691271
Orange5061033692926

How the issue was identified

The company said the matter was identified during a California Department of Public Health inspection that raised questions regarding regulatory authorization and related production records for certain distributed products. Diva Fam said it is cooperating fully with regulatory authorities and initiated the voluntary recall to ensure regulatory alignment.

The company said the recall is being conducted with the knowledge of the U.S. Food and Drug Administration.

What consumers should do

  • Discontinue use of the affected product.
  • Follow the instructions provided by the place of purchase regarding product return or disposal.
  • Contact the company for additional information (details below).

Consumer and media contact

Consumers seeking additional information may contact:

  • Email: support@divafam.com
  • Phone: (818) 751-3882
  • Hours: Monday through Friday, 9:00 a.m. – 5:00 p.m. Pacific Time

Source: Diva Fam Inc. (PRNewswire, Jan. 9, 2026)

https://stmdailynews.com/culvers-thank-you-farmers-project-hits-8-million-donation-milestone/

Authors


Discover more from Daily News

Subscribe to get the latest posts sent to your email.

Continue Reading

The Latest from Sleeve’s SPR: Sleeve's Senior Pickleball Report

Ace Pickleball Club Launches National Player Development Series

Ace Pickleball Club Launches National Player Development Series

Ace Pickleball Club launches a national Player Development Series with four training levels, plus free Intro to Pickleball clinics. Learn what’s included and how to sign up.

Trending